
Cybersecurity Vulnerabilities with Certain Patient Monitors from Contec and Epsimed: FDA Safety Communication
Today, the U.S. Food and Drug Administration (FDA) issued a safety communication to raise awareness about cybersecurity vulnerabilities in Contec CMS8000 patient monitors and Epsimed MN-120 patient monitors. These medical devices are used in health care and home settings for displaying information, such as the vital signs of a patient, including temperature, heartbeat, and blood pressure.
The FDA is not aware of any cybersecurity incidents, injuries, or deaths related to these cybersecurity vulnerabilities at this time.
This safety communication provides:
- Recommendations for patients and their caregivers.
- Recommendations for health care providers and facilities.
- Background on the issue and the FDA’s actions to address the issue.
- Instructions for reporting problems with Contec CMS8000 or Epsimed MN-120 patient monitors to the FDA.
Questions?
If you have questions about this safety communication, contact the Division of Industry and Consumer Education (DICE)
|